Steven provided a glimpse into the evolving landscape of pharmaceutical pricing and contracting, with a focus on strategic pricing, stakeholder alignment, and operational efficiency. The presentation provides actionable insights into how list price decisions impact government pricing, gross-to-net forecasting, and payer reimbursement. This was followed by a robust discussion between Steven and a panel of industry experts.